CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle

Carol A. Witczak, Niels Jessen, Daniel M. Warro, Taro Toyoda, Nobuharu Fujii, Mark Anderson, Michael F. Hirshman, Laurie J. Goodyear

Research output: Contribution to journalArticle

Abstract

Studies using chemical inhibitors have suggested that the Ca 2+-sensitive serine/threonine kinase Ca2+/calmodulin- dependent protein kinase II (CaMKII) is a key regulator of both insulin- and contraction-stimulated glucose uptake in skeletal muscle. However, due to nonspecificity of these inhibitors, the specific role that CaMKII may play in the regulation of glucose uptake is not known. We sought to determine whether specific inhibition of CaMKII impairs insulin- and/or contraction-induced glucose uptake in mouse skeletal muscle. Expression vectors containing green fluorescent protein conjugated to a CaMKII inhibitory (KKALHRQEAVDCL) or control (KKALHAQERVDCL) peptide were transfected into tibialis anterior muscles by in vivo electroporation. After 1 wk, muscles were assessed for peptide expression, CaMK activity, insulin- and contraction-induced 2-[3H]deoxyglucose uptake, glycogen concentrations, and changes in intracellular signaling proteins. Expression of the CaMKII inhibitory peptide decreased muscle CaMK activity ∼35% compared with control peptide. Insulin-induced glucose uptake was not changed in muscles expressing the inhibitory peptide. In contrast, expression of the inhibitory peptide significantly decreased contraction-induced muscle glucose uptake (∼30%). Contraction-induced decreases in muscle glycogen were not altered by the inhibitory peptide. The CaMKII inhibitory peptide did not alter expression of the glucose transporter GLUT4 and did not impair contraction-induced increases in the phosphorylation of AMP-activated protein kinase (Thr172) or TBC1D1/TBC1D4 on phospho-Akt substrate sites. These results demonstrate that CaMKII does not regulate insulin-stimulated glucose uptake in skeletal muscle. However, CaMKII plays a critical role in the regulation of contraction-induced glucose uptake in mouse skeletal muscle.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume298
Issue number6
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinase Type 2
Skeletal Muscle
Insulin
Glucose
Peptides
Muscles
Glycogen
Intracellular Signaling Peptides and Proteins
AMP-Activated Protein Kinases
Electroporation
Facilitative Glucose Transport Proteins
Protein-Serine-Threonine Kinases
Deoxyglucose
Muscle Contraction
Green Fluorescent Proteins
Phosphorylation

Keywords

  • Ca signaling
  • Ca/calmodulin-dependent protein kinase II
  • Exercise
  • Metabolism

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle. / Witczak, Carol A.; Jessen, Niels; Warro, Daniel M.; Toyoda, Taro; Fujii, Nobuharu; Anderson, Mark; Hirshman, Michael F.; Goodyear, Laurie J.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 298, No. 6, 06.2010.

Research output: Contribution to journalArticle

Witczak, Carol A. ; Jessen, Niels ; Warro, Daniel M. ; Toyoda, Taro ; Fujii, Nobuharu ; Anderson, Mark ; Hirshman, Michael F. ; Goodyear, Laurie J. / CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle. In: American Journal of Physiology - Endocrinology and Metabolism. 2010 ; Vol. 298, No. 6.
@article{882d6a499d844bf09374a1ade98eeee3,
title = "CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle",
abstract = "Studies using chemical inhibitors have suggested that the Ca 2+-sensitive serine/threonine kinase Ca2+/calmodulin- dependent protein kinase II (CaMKII) is a key regulator of both insulin- and contraction-stimulated glucose uptake in skeletal muscle. However, due to nonspecificity of these inhibitors, the specific role that CaMKII may play in the regulation of glucose uptake is not known. We sought to determine whether specific inhibition of CaMKII impairs insulin- and/or contraction-induced glucose uptake in mouse skeletal muscle. Expression vectors containing green fluorescent protein conjugated to a CaMKII inhibitory (KKALHRQEAVDCL) or control (KKALHAQERVDCL) peptide were transfected into tibialis anterior muscles by in vivo electroporation. After 1 wk, muscles were assessed for peptide expression, CaMK activity, insulin- and contraction-induced 2-[3H]deoxyglucose uptake, glycogen concentrations, and changes in intracellular signaling proteins. Expression of the CaMKII inhibitory peptide decreased muscle CaMK activity ∼35{\%} compared with control peptide. Insulin-induced glucose uptake was not changed in muscles expressing the inhibitory peptide. In contrast, expression of the inhibitory peptide significantly decreased contraction-induced muscle glucose uptake (∼30{\%}). Contraction-induced decreases in muscle glycogen were not altered by the inhibitory peptide. The CaMKII inhibitory peptide did not alter expression of the glucose transporter GLUT4 and did not impair contraction-induced increases in the phosphorylation of AMP-activated protein kinase (Thr172) or TBC1D1/TBC1D4 on phospho-Akt substrate sites. These results demonstrate that CaMKII does not regulate insulin-stimulated glucose uptake in skeletal muscle. However, CaMKII plays a critical role in the regulation of contraction-induced glucose uptake in mouse skeletal muscle.",
keywords = "Ca signaling, Ca/calmodulin-dependent protein kinase II, Exercise, Metabolism",
author = "Witczak, {Carol A.} and Niels Jessen and Warro, {Daniel M.} and Taro Toyoda and Nobuharu Fujii and Mark Anderson and Hirshman, {Michael F.} and Goodyear, {Laurie J.}",
year = "2010",
month = "6",
doi = "10.1152/ajpendo.00659.2009",
language = "English (US)",
volume = "298",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "6",

}

TY - JOUR

T1 - CaMKII regulates contraction- but not insulin-induced glucose uptake in mouse skeletal muscle

AU - Witczak, Carol A.

AU - Jessen, Niels

AU - Warro, Daniel M.

AU - Toyoda, Taro

AU - Fujii, Nobuharu

AU - Anderson, Mark

AU - Hirshman, Michael F.

AU - Goodyear, Laurie J.

PY - 2010/6

Y1 - 2010/6

N2 - Studies using chemical inhibitors have suggested that the Ca 2+-sensitive serine/threonine kinase Ca2+/calmodulin- dependent protein kinase II (CaMKII) is a key regulator of both insulin- and contraction-stimulated glucose uptake in skeletal muscle. However, due to nonspecificity of these inhibitors, the specific role that CaMKII may play in the regulation of glucose uptake is not known. We sought to determine whether specific inhibition of CaMKII impairs insulin- and/or contraction-induced glucose uptake in mouse skeletal muscle. Expression vectors containing green fluorescent protein conjugated to a CaMKII inhibitory (KKALHRQEAVDCL) or control (KKALHAQERVDCL) peptide were transfected into tibialis anterior muscles by in vivo electroporation. After 1 wk, muscles were assessed for peptide expression, CaMK activity, insulin- and contraction-induced 2-[3H]deoxyglucose uptake, glycogen concentrations, and changes in intracellular signaling proteins. Expression of the CaMKII inhibitory peptide decreased muscle CaMK activity ∼35% compared with control peptide. Insulin-induced glucose uptake was not changed in muscles expressing the inhibitory peptide. In contrast, expression of the inhibitory peptide significantly decreased contraction-induced muscle glucose uptake (∼30%). Contraction-induced decreases in muscle glycogen were not altered by the inhibitory peptide. The CaMKII inhibitory peptide did not alter expression of the glucose transporter GLUT4 and did not impair contraction-induced increases in the phosphorylation of AMP-activated protein kinase (Thr172) or TBC1D1/TBC1D4 on phospho-Akt substrate sites. These results demonstrate that CaMKII does not regulate insulin-stimulated glucose uptake in skeletal muscle. However, CaMKII plays a critical role in the regulation of contraction-induced glucose uptake in mouse skeletal muscle.

AB - Studies using chemical inhibitors have suggested that the Ca 2+-sensitive serine/threonine kinase Ca2+/calmodulin- dependent protein kinase II (CaMKII) is a key regulator of both insulin- and contraction-stimulated glucose uptake in skeletal muscle. However, due to nonspecificity of these inhibitors, the specific role that CaMKII may play in the regulation of glucose uptake is not known. We sought to determine whether specific inhibition of CaMKII impairs insulin- and/or contraction-induced glucose uptake in mouse skeletal muscle. Expression vectors containing green fluorescent protein conjugated to a CaMKII inhibitory (KKALHRQEAVDCL) or control (KKALHAQERVDCL) peptide were transfected into tibialis anterior muscles by in vivo electroporation. After 1 wk, muscles were assessed for peptide expression, CaMK activity, insulin- and contraction-induced 2-[3H]deoxyglucose uptake, glycogen concentrations, and changes in intracellular signaling proteins. Expression of the CaMKII inhibitory peptide decreased muscle CaMK activity ∼35% compared with control peptide. Insulin-induced glucose uptake was not changed in muscles expressing the inhibitory peptide. In contrast, expression of the inhibitory peptide significantly decreased contraction-induced muscle glucose uptake (∼30%). Contraction-induced decreases in muscle glycogen were not altered by the inhibitory peptide. The CaMKII inhibitory peptide did not alter expression of the glucose transporter GLUT4 and did not impair contraction-induced increases in the phosphorylation of AMP-activated protein kinase (Thr172) or TBC1D1/TBC1D4 on phospho-Akt substrate sites. These results demonstrate that CaMKII does not regulate insulin-stimulated glucose uptake in skeletal muscle. However, CaMKII plays a critical role in the regulation of contraction-induced glucose uptake in mouse skeletal muscle.

KW - Ca signaling

KW - Ca/calmodulin-dependent protein kinase II

KW - Exercise

KW - Metabolism

UR - http://www.scopus.com/inward/record.url?scp=77952650308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952650308&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00659.2009

DO - 10.1152/ajpendo.00659.2009

M3 - Article

VL - 298

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 6

ER -